Skip to main content

Main menu

  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us

Clinical Medicine Journal

  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

User menu

  • Log in

Search

  • Advanced search
RCP Journals
Home
  • Log in
  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us
Advanced

Clinical Medicine Journal

clinmedicine Logo
  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

Adrenal insufficiency – recognition and management

Oscar M P Jolobe
Download PDF
DOI: https://doi.org/10.7861/clinmedicine.17-5-480a
Clin Med October 2017
Oscar M P Jolobe
Manchester Medical Society, Manchester, UK
Roles: Retired geriatrician
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

The observation that Addison’s disease may present as an unexplained reduction in insulin requirement in an individual with diabetes mellitus1 has, as its corollary, the observation that a requirement for an unusually large dose of hydrocortisone (over and above concurrent fludrocortisone therapy) to maintain an adequate blood pressure (BP) might signify that Addison’s disease coexists with hitherto unrecognised thyrotoxicosis.2 This was the case in a 74-year-old man who had initially presented with Addisonian crisis characterised by BP 70/40 mmHg and a pulse rate 130 bpm. The diagnosis of Addison’s disease was subsequently validated by a positive synacthen test. Nevertheless, despite the fact that hydrocortisone was co-prescribed with fludrocortisone, he required as much as 80 mg/day of hydrocortisone to maintain a BP 120/80 mgHg. The fact that tachycardia also persisted raised the index of suspicion for thyrotoxicosis, a diagnosis that was duly validated by free thyroxine and tri-iodothyronine levels of 45.3 nmol/L (normal 10–30) and 5.9 nmol/L (normal 0.8–3), respectively. A flat response to the thyrotropin-releasing hormone test clinched the diagnosis. Following treatment with carbimazole he became euthyroid and his pulse rate fell to 68 bpm. It also subsequently became possible to reduce the dose of hydrocortisone to a level of 30 mg/day, which maintained him in good health.2

A comparable scenario was documented in a 42-year-old woman in whom the initial diagnosis was Addison’s disease and in whom treatment with prednisolone 5 mg twice per day resulted in a 1.5-year period of relief of symptoms.

Subsequently, however, she experienced two episodes of Addisonian crisis 4 months apart. The maintenance dose of prednisolone was then increased to 10 mg in the morning and 5 mg in the evening, and this was co-prescribed with fludrocortisone 50 μg/day. Following identification of thyrotoxicosis as the precipitating cause of adrenal crisis, she was rendered euthyroid by means of carbimazole, followed by radioiodine. After she became euthyroid, she remained symptom free and gained 8 kg in weight while taking prednisolone 5 mg/day and fludrocortisone 50 μg/day.3

Although the association of Addison’s disease and thyrotoxicosis is rare,2–5there should be a heightened index of suspicion for coexisting thyrotoxicosis when symptoms and signs of hypoadrenalism persist despite progressively increasing doses of replacement therapy4 or when a previously well managed patient experiences Addisonian crisis without an obvious precipitating cause.

Conflicts of interest

The author has no conflicts of interest to declare.

  • © Royal College of Physicians 2017. All rights reserved.

References

  1. ↵
    1. Pazderska A
    , Pearce S. Adrenal insufficiency – recognition and ­management. Clin Med 2017;17:258–62.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Newrick PG.
    Addison’s disease and thyrotoxicosis presenting ­simultaneously. Postgrad Med J 1984;60:478–9.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Naik D
    , Jebasingh KF, Thomas N. Delayed diagnosis of Grave’s ­thyrotoxicosis presenting as recurrent adrenal crisis in primary adrenal insufficiency. J Clin Diagn Res 2016;10:OD20–2.
    OpenUrl
  4. ↵
    1. Ranganath L
    , Gould SR. Increasing need for replacement therapy in long-standing Addison’s disease. Postgrad Med J 1998;74:291–3.
    OpenUrlFREE Full Text
    1. Bruno MS
    , Ober WB, Kupperman HS, et al. Coexistent Addison’s disease and thyrotoxicosis. Arch Intern Med 1962;110:155–61.
    OpenUrlCrossRefPubMed
Back to top
Previous articleNext article

Article Tools

Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Adrenal insufficiency – recognition and management
Oscar M P Jolobe
Clinical Medicine Oct 2017, 17 (5) 480; DOI: 10.7861/clinmedicine.17-5-480a

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Adrenal insufficiency – recognition and management
Oscar M P Jolobe
Clinical Medicine Oct 2017, 17 (5) 480; DOI: 10.7861/clinmedicine.17-5-480a
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Conflicts of interest
    • References
  • Info & Metrics

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • The association of pleural effusion and pulmonary embolism
  • What is the impact of COVID-19 on complaints against doctors?
  • The significance of the gut microbiome in post-COVID-19 gastrointestinal symptoms
Show more Letters to the editor

Similar Articles

FAQs

  • Difficulty logging in.

There is currently no login required to access the journals. Please go to the home page and simply click on the edition that you wish to read. If you are still unable to access the content you require, please let us know through the 'Contact us' page.

  • Can't find the CME questionnaire.

The read-only self-assessment questionnaire (SAQ) can be found after the CME section in each edition of Clinical Medicine. RCP members and fellows (using their login details for the main RCP website) are able to access the full SAQ with answers and are awarded 2 CPD points upon successful (8/10) completion from:  https://cme.rcplondon.ac.uk

Navigate this Journal

  • Journal Home
  • Current Issue
  • Ahead of Print
  • Archive

Related Links

  • ClinMed - Home
  • FHJ - Home
clinmedicine Footer Logo
  • Home
  • Journals
  • Contact us
  • Advertise
HighWire Press, Inc.

Follow Us:

  • Follow HighWire Origins on Twitter
  • Visit HighWire Origins on Facebook

Copyright © 2021 by the Royal College of Physicians